“IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA”. 2025. Frontier in Medical and Health Research 3 (10): 570-77. https://fmhr.net/index.php/fmhr/article/view/1765.